AdAge has a report out today noting that Time Warner CEO, Jeffrey L. Bewkes, plans to lay off 75 or more people tomorrow. But this report says the cuts are coming primarily from the company's corporate offices. That would be much closer to home for the top brass there, so 75 of the 600 to 700 noted in the article would be a substantial signal that the company is making sacrifices top to bottom in a quest for shareholder rewards.
If this is the case, it would be coincidental with earnings, also scheduled for tomorrow morning. Bewkes still has time on his side to make his mark. Now that Carl Icahn isn't in the middle of the hornet's nest, the current shareholder base has become patient. A bear market trading pattern forces people to stop badgering CEOs so much, because relative performance gets harder and harder to prove.
This is Bewkes' first earnings report as head honcho there, but Dick Parsons was still in charge for most of this last quarter. Bewkes may go over a formal plan and he might not. Most likely the media conglomerate will outline a formal date that the actual plan will be announced.
Obviously, most of BloggingStocks' attention is probably going to pertain to Bewkes' forward plans for AOL. Many of the mega-merger watchers from last week think this puts added pressure on AOL, although that might not really be the case. Since that is opinion, I will hold off on going into details on that.
Time Warner Inc. (NYSE: TWX) shares closed down 2.7% today at $15.40. The 52-week trading range is $14.64 to $21.97. Stay tuned for earnings tomorrow.
Last updated: February 10, 2012: 05:19 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- January New Home Sales to be released at 10:00 ET
- February Consumer Sentiment to be released at 09:55 ET
- Churchill Downs acquires assets of Bluff Media
- Mario Monti: Far from certain there will be a Greek default, CNBC reports
- Energen to acquire proved Wolfberry properties
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Savings Experiment: Snow Removal
Why Your 2012 Tax Bill May Jump By $8,000

